newsfilter
← Latest News
GlobeNewswire·

Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale,